A Family Case of COVID-19 Pneumonia with Different Chest CT Features and Duration of SARS-CoV-2 Shedding: a Case Report from Japan

Ochiai, Shigeki; Kama, Yuichi; Hirai, Kota; Yano, Hidetoshi; Tada, Ayumi; Kaiga, Chinami; Sakama, Takashi; Takakura, Hiromitsu; Yamaguchi, Koichi; Mochizuki, Hiroyasu; Katô, Masahiko

doi:10.7883/yoken.jjid.2021.019

Cited by 1 publication

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the older children might be required longer treatment because of the longer viral shedding. 36 So, we still believe that our data provides valuable information due to its effect on mortality. It will be noticed that in the high-dose group, the need for respiratory support did not move on from NIMV to IMV (28.9% vs. 14.9%) and mortality was lower.…”

Section: Discussionmentioning

confidence: 85%

See 1 more Smart Citation

Methylprednisolone use in children with severe pneumonia caused by severe acute respiratory syndrome coronavirus 2

Ozsurekci,

Aykac,

Demir

et al. 2023

Pediatrics International

View full text Add to dashboard Cite

BackgroundThis study aimed to evaluate the effectiveness and optimal use of corticosteroids in children with severe coronavirus disease 2019 (COVID‐19) pneumonia, for which effective treatment is still lacking with respect to this population.MethodsWe conducted a retrospective study and included patients (aged < 18 years) with severe COVID‐19 pneumonia and/or acute respiratory distress syndrome (ARDS) who received standard doses (2–4 mg/kg/day) and high doses (>250 mg/day) of methylprednisolone (MPZ). We adjusted for patients on steroid treatments with a propensity score and compared the side effects of different MPZ doses and patient survival.ResultsFifty‐nine patients were included: 61% were male, the median age was 8, interquartile range (IQR) 2–15) years. The overall survival was 84.4% in patients treated with standard‐dose MPZ (n = 45, 76.3%) and 92.2% in patients treated with high‐dose MPZ (n = 14, 23.7%; p = 0.67). The demographic, clinical, and laboratory data did not differ significantly after propensity score matching, apart from bradycardia, which was a prominent feature of the high‐dose group. The clinical and radiological response rates on day 7 were higher and the need for invasive mechanical ventilation (IMV) was lower in the high‐dose group.ConclusionThe patients with high‐dose MPZ had better clinical and radiological responses than those with standard‐dose MPZ, although the mortality rate did not differ between standard and high‐dose regimens of MPZ.

show abstract

Section: Discussionmentioning

confidence: 85%

“…In this case this is a kind of bias. However, the older children might be required longer treatment because of the longer viral shedding 36 . So, we still believe that our data provides valuable information due to its effect on mortality.…”

Section: Discussionmentioning

confidence: 87%